Benign/Likely benign
Multiple submitters
Classification
Benign/Likely benign
ClinVar
Review
Multiple submitters ★★☆☆
ClinVar · 6 submitters
gnomAD v4.1
Rare
low-frequency (popmax 1.95%, afr)
Conditions
1
holocarboxylase synthetase deficiency
Computational evidence
| Protein change | ||
| Missense predictors do not apply to this variant type; conservation carries the signal. | ||
| Splicing | ||
| SpliceAI | — | not assessed · no allele here is in the release |
|---|---|---|
| Constraint at this position | ||
| Conservation | phyloP -7.8 | GERP -4 |
| Overall | ||
| CADD | 0.178 | PHRED · no single calibrated threshold — expert panels disagree |
Population frequency
gnomAD v4.1 · exomes + genomes
Grpmax group
1.95%
African / African-American · 1,462/74,980 alleles
Filtering AF
1.87%
ClinGen BA1/BS1 input
FAF95, joint · FAF99 1.83%
Overall
0.127%
2,057/1,614,046 alleles · low-frequency
exomes 1,233/1,461,878 · genomes 824/152,168 · joint denominator
| Ancestry group | Frequency | 1 in |
|---|---|---|
| African / African-Americangrpmax | 1.95% | 51 |
| Middle Eastern | 0.396% | 253 |
| Ashkenazi Jewishnot grpmax-eligible | 0.243% | 411 |
| Remaining individualsnot grpmax-eligible | 0.237% | 422 |
| Admixed American | 0.203% | 492 |
| European (non-Finnish) | 0.018% | 5,566 |
| South Asian | 0.0154% | 6,505 |
| East Asian | 0.00669% | 14,958 |
Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.
Variant & gene context
- Gene
- HLCS
- Protein
- p.Pro242=
- Coding
- c.726C>T
- MANE Select
- NM_001352514
- dbSNP
- rs2230182
- Type
- single nucleotide variant
- Location
- chr21:36937160 (GRCh38)
- Gene constraint
- LOEUF 0.883 · pLI <0.01 · ClinGen HI gene assoc. with recessive phenotype (gnomAD)
- Structure
- AlphaFold pLDDT 77.33
Disease context
holocarboxylase synthetase deficiency — disease report on Sugi Atlas → Associated genes, phenotypes, clinical trials & treatmentsFor Holocarboxylase synthetase deficiency (Orphanet):
- Inheritance
- Autosomal recessive
- Onset
- Childhood, Infancy, Neonatal
- Prevalence
- 1-9 / 1 000 000 (Europe)
Similar variants
- HLCS c.1620+2T>G Likely pathogenic ★★ same condition
- HLCS c.1621-2A>G Likely pathogenic ★★ same condition
- HLCS c.1892+1G>A Likely pathogenic ★★ same condition
- HLCS c.1960+5G>A Pathogenic ★★ same condition
- HLCS c.2121+1G>A Pathogenic/Likely pathogenic ★★ same condition
- HLCS c.2237-2A>G Likely pathogenic ★★ same condition
- HLCS c.2450+2T>A Likely pathogenic ★★ same condition
- HLCS c.2451-1G>A Pathogenic/Likely pathogenic ★★ same condition
Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →
Cite Sugi Variant
Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/hlcs-p-pro242 (accessed [today's date]).
Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown